This is the protocol for a review and there is no abstract. The objectives are as follows: To investigate the effects of non-monthly versus monthly intravitreal injection of an anti-VEGF agent on best-corrected visual acuity (BCVA) in people with newly diagnosed nAMD at one-year follow-up.
Treatment schedules for administration of anti-vascular endothelial growth factor agents for neovascular age-related macular degeneration
DONATI, SIMONEInvestigation
;
2016-01-01
Abstract
This is the protocol for a review and there is no abstract. The objectives are as follows: To investigate the effects of non-monthly versus monthly intravitreal injection of an anti-VEGF agent on best-corrected visual acuity (BCVA) in people with newly diagnosed nAMD at one-year follow-up.
File in questo prodotto:
Non ci sono file associati a questo prodotto.
I documenti in IRIS sono protetti da copyright e tutti i diritti sono riservati, salvo diversa indicazione.
